Aveanna Healthcare Holdings Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | -$0.05 | -$0.05 | -$0.05 |
Q2 2024 | 2 | -$0.02 | -$0.02 | -$0.02 |
Q3 2024 | 6 | -$0.03 | $0.01 | -$0.01 |
Q4 2024 | 2 | $0.00 | $0.00 | $0.00 |
Q1 2025 | 4 | $0.00 | $0.00 | $0.00 |
Q2 2025 | 4 | $0.03 | $0.03 | $0.03 |
Q3 2025 | 4 | $0.02 | $0.02 | $0.02 |
Q4 2025 | 4 | $0.03 | $0.03 | $0.03 |
Q1 2026 | 2 | $0.03 | $0.04 | $0.04 |
Q2 2026 | 2 | $0.04 | $0.04 | $0.04 |
Q3 2026 | 2 | $0.03 | $0.04 | $0.04 |
Q4 2026 | 2 | $0.05 | $0.05 | $0.05 |
Aveanna Healthcare Holdings Inc. Earnings Date And Information
Aveanna Healthcare Holdings Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of $0.004 by $0.006. The company had revenue of 504.96 M for the quarter and had revenue of 1.90 B for the year. Aveanna Healthcare Holdings Inc. has generated $-1 earnings per share over the last year ($-0.71 diluted earnings per share) and currently has a price-to-earnings ratio of -8.45. Aveanna Healthcare Holdings Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
Aveanna Healthcare Holdings Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/08/2024 | Q2 2024 | $0.00 | $0.07 | 0.07 | $493.49 M | $504.96 M |
05/09/2024 | Q1 2024 | -$0.05 | -$0.06 | -0.01 | $490.65 M | |
03/14/2024 | Q4 2023 | -$0.01 | -$0.13 | -0.12 | $478.84 M | |
11/09/2023 | Q3 2023 | -$0.03 | -$0.54 | -0.51 | $478.01 M | |
08/10/2023 | Q2 2023 | -$0.01 | $0.14 | 0.15 | $471.95 M | |
05/11/2023 | Q1 2023 | -$0.06 | -$0.17 | -0.11 | $466.41 M | |
03/16/2023 | Q4 2022 | -$0.02 | -$1.28 | -1.26 | $451.15 M | |
11/15/2022 | Q3 2022 | $0.13 | $443.01 M | |||
08/10/2022 | Q2 2022 | -$2.56 | $442.96 M | |||
05/11/2022 | Q1 2022 | $0.06 | $0.14 | 0.08 | $450.53 M | |
03/28/2022 | Q4 2021 | $0.11 | -$0.68 | -0.79 | $414.07 M | |
11/15/2021 | Q3 2021 | $0.12 | $0.01 | -0.11 | $411.28 M | |
08/11/2021 | Q2 2021 | $0.10 | $0.01 | -0.09 | $436.11 M | |
05/25/2021 | Q1 2021 | $0.07 | $0.03 | -0.04 | $417.16 M | |
12/31/2020 | Q4 2020 | -$0.07 | $422.30 M | |||
09/29/2020 | Q3 2020 | -$0.04 | $366.00 M | |||
06/29/2020 | Q2 2020 | -$0.43 | $351.58 M | |||
03/30/2020 | Q1 2020 | $0.21 | $355.22 M |
Aveanna Healthcare Holdings Inc. Earnings: Frequently Asked Questions
-
When is Aveanna Healthcare Holdings Inc.'s earnings date?
Aveanna Healthcare Holdings Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
Did Aveanna Healthcare Holdings Inc. beat their earnings estimates last quarter?
In the previous quarter, Aveanna Healthcare Holdings Inc. (:AVAH) reported $0.01 earnings per share (EPS) to beat the analysts' consensus estimate of $0.004 by $0.006.
-
How can I listen to Aveanna Healthcare Holdings Inc.'s earnings conference call?
The conference call for Aveanna Healthcare Holdings Inc.'s latest earnings report can be listened to online.
-
How can I read Aveanna Healthcare Holdings Inc.'s conference call transcript?
The conference call transcript for Aveanna Healthcare Holdings Inc.'s latest earnings report can be read online.
-
How much revenue does Aveanna Healthcare Holdings Inc. generate each year?
Aveanna Healthcare Holdings Inc. (:AVAH) has a recorded annual revenue of $1.90 B.
-
How much profit does Aveanna Healthcare Holdings Inc. generate each year?
Aveanna Healthcare Holdings Inc. (:AVAH) has a recorded net income of $1.90 B. Aveanna Healthcare Holdings Inc. has generated $-0.71 earnings per share over the last four quarters.
-
What is Aveanna Healthcare Holdings Inc.'s price-to-earnings ratio?
Aveanna Healthcare Holdings Inc. (:AVAH) has a price-to-earnings ratio of -8.45 and price/earnings-to-growth ratio is -1.03.